1. Home
  2. ESCA vs SAVA Comparison

ESCA vs SAVA Comparison

Compare ESCA & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ESCA

Escalade Incorporated

N/A

Current Price

$12.81

Market Cap

161.4M

ML Signal

N/A

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$3.24

Market Cap

157.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
SAVA
Founded
1922
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.4M
157.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ESCA
SAVA
Price
$12.81
$3.24
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
18.7K
1.1M
Earning Date
10-30-2025
11-12-2025
Dividend Yield
4.72%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$241,540,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.00
N/A
P/E Ratio
$13.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.41
$1.15
52 Week High
$16.99
$4.98

Technical Indicators

Market Signals
Indicator
ESCA
SAVA
Relative Strength Index (RSI) 52.63 52.90
Support Level $12.49 $3.13
Resistance Level $13.09 $3.38
Average True Range (ATR) 0.43 0.22
MACD -0.04 0.05
Stochastic Oscillator 42.67 75.15

Price Performance

Historical Comparison
ESCA
SAVA

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: